Why is Metropolis Healt falling/rising?

As of 24-Jul, Metropolis Healthcare Ltd is experiencing a price increase, currently at 2,026.10, reflecting a rise of 22.1 or 1.1%. The stock has shown a positive trend, gaining 4.67% over the last three days and outperforming the Sensex with a weekly return of 3.95% compared to the benchmark's slight decline of 0.09%. Despite a decrease in investor participation, indicated by a 47.97% drop in delivery volume, the stock is trading above its moving averages across various time frames, suggesting strong short-term momentum. Additionally, the company benefits from high management efficiency, evidenced by a return on capital employed (ROCE) of 26.87% and a low debt-to-equity ratio, which may attract institutional investors, as reflected in the high institutional holdings of 45.58%.
In the broader market context, while Metropolis Healthcare has shown positive short-term performance, it has underperformed the Sensex year-to-date with a decline of 1.81% against the benchmark's gain of 5.18%. The stock's long-term growth prospects appear concerning, with net sales and operating profit growth lagging behind expectations, and recent quarterly results showing significant declines in profit before tax and profit after tax. Furthermore, despite the stock trading at a discount compared to its peers, its expensive valuation metrics, such as a price-to-book value of 7.9 and a PEG ratio of 6, may deter some investors, contributing to the mixed sentiment surrounding its future performance.